Literature DB >> 9303203

Of microbes, macrophages and nitric oxide.

C Bogdan1.   

Abstract

One of the most prominent functions of nitric oxide (NO) is its participation in antimicrobial and antiviral defense. This paper summarizes the evidence for this function and compiles the infectious agents which are currently thought to be controlled via high out-put generation of NO as it occurs in activated macrophages and other cells expressing the inducible isoform of NO-synthase (iNOS, NOS-2). Several less appreciated forms of interaction between NO and microbes will also be reviewed, including the role of NO as an immunosuppressive or tissue-destructive molecule during the course of infections, the regulation of microbial antioxidant systems by host cell-derived NO, the contribution of NO to parasite stage conversion, the induction or suppression of macrophage iNOS by microbial products, and the existence of endogenous NO synthase pathways in certain bacteria and parasites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303203

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  15 in total

1.  Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.

Authors:  Sheila Donnelly; Sandra M O'Neill; Mary Sekiya; Grace Mulcahy; John P Dalton
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Liver injury and abscess formation in secondary murine peritonitis.

Authors:  Andreas M Lenz; Mark Fairweather; James C Peyton; Sarah A Gardner; William G Cheadle
Journal:  Inflamm Res       Date:  2010-10-26       Impact factor: 4.575

3.  Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.

Authors:  Christine Roshick; Heidi Wood; Harlan D Caldwell; Grant McClarty
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.

Authors:  David Piedrafita; Endah Estuningsih; Jill Pleasance; Rhoda Prowse; Herman W Raadsma; Els N T Meeusen; Terry W Spithill
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

5.  From inflammation to wound healing: using a simple model to understand the functional versatility of murine macrophages.

Authors:  Lauren M Childs; Michael Paskow; Sidney M Morris; Matthias Hesse; Steven Strogatz
Journal:  Bull Math Biol       Date:  2011-02-23       Impact factor: 1.758

6.  NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads.

Authors:  S Ehlers; S Kutsch; J Benini; A Cooper; C Hahn; J Gerdes; I Orme; C Martin; E T Rietschel
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

7.  The TLR4-NOS1-AP1 signaling axis regulates macrophage polarization.

Authors:  Mansi Srivastava; Uzma Saqib; Adnan Naim; Anjali Roy; Dongfang Liu; Deepak Bhatnagar; Ravinder Ravinder; Mirza Saqib Baig
Journal:  Inflamm Res       Date:  2016-12-24       Impact factor: 4.575

8.  NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease.

Authors:  M Hesse; A W Cheever; D Jankovic; T A Wynn
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

9.  Effect of peroxynitrite on dormant spores and germlings of Aspergillus fumigatus in vitro.

Authors:  J Kunert
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

10.  Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice.

Authors:  Viktor Brovkovych; Xiao-Pei Gao; Evan Ong; Svitlana Brovkovych; Marie-Luise Brennan; Xiao Su; Stanley L Hazen; Asrar B Malik; Randal A Skidgel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.